WILLIAM Y. CHEY, M.D., D.SC.; T.-M. CHANG, Ph.D.; HYOUNG JIN PARK, M.D.; KAE YOL LEE, M.D.; ROBERT ESCOFFERY, B.SC.; YUAN FANG CHEN, M.D.; ASHOK N. SHAH, M.D.; DAVID HAMILTON, M.D.; CHUL H. YOU, M.D.; RENE MENGUY, M.D., Ph.D.
In 18 patients with hypersecretion of acid, severe ulcer diathesis, and pancreatic islet cell tumor or hyperplasia, 14 had hypergastrinemia and 4 had normal plasma gastrin concentration. The neoplasms contained several gut peptides beside gastrin. The immunoreactive gastrin in the tumor extracts measured less than 7 ng/g, less than the amount previously reported. The extracts of each patient's tumor also contained a secretogogue other than gastrin that stimulated gastric acid secretion in rats. In addition, the plasma extracts of 2 patients also contained a secretogogue that stimulated acid secretion. After surgical resection of a recurrent metastatic tumor in 1 patient, basal acid secretion decreased from 13.9 to less than 1 meq/h, and the bioactivity of the plasma disappeared. These observations suggest the existence of a secretogogue that appears to be a protein in the pancreatic tumors of some patients with severe ulcer diathesis and hypersecretion.
CHEY WY, CHANG T, PARK HJ, et al. A Non-Gastrin Secretogogue in Ulcerogenic Tumors of the Pancreas. Ann Intern Med. 1984;101:7–13. doi: https://doi.org/10.7326/0003-4819-101-1-7
Download citation file:
Published: Ann Intern Med. 1984;101(1):7-13.
Gastroenterology/Hepatology, Hematology/Oncology, Pancreatic Disease.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use